Massachusetts Financial Services
ANIK icon

Massachusetts Financial Services’s Anika Therapeutics ANIK Stock Holding History

Massachusetts Financial Services’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Sell
71,758
-2,861
-4% -$42.4K ﹤0.01% 885
2026
Q1 		$1.08M Buy
74,619
+28,241
+61% +$328K ﹤0.01% 841
2025
Q4 		$446K Sell
46,378
-1,533
-3% -$14.7K ﹤0.01% 878
2025
Q3 		$450K Buy
47,911
+3,150
+7% +$30.1K ﹤0.01% 834
2025
Q2 		$474K Buy
44,761
+554
+1% +$6.99K ﹤0.01% 851
2025
Q1 		$664K Sell
44,207
-1,006
-2% -$16.7K ﹤0.01% 832
2024
Q4 		$744K Sell
45,213
-1,351
-3% -$26.6K ﹤0.01% 827
2024
Q3 		$1.15M Sell
46,564
-1,127
-2% -$29.2K ﹤0.01% 788
2024
Q2 		$1.21M Buy
47,691
+1,601
+3% +$41.5K ﹤0.01% 787
2024
Q1 		$1.17M Buy
+46,090
New +$1.12M ﹤0.01% 776
2014
Q2 		– Sell
-15,510
Closed -$637K – 889
2014
Q1 		$637K Sell
15,510
-14,530
-48% -$540K ﹤0.01% 808
2013
Q4 		$1.15M Buy
30,040
+12,340
+70% +$381K ﹤0.01% 712
2013
Q3 		$423K Sell
17,700
-650
-4% -$14.6K ﹤0.01% 797
2013
Q2 		$312K Buy
+18,350
New +$265K ﹤0.01% 783

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

Massachusetts Financial Services's ANIK Position: Q2 2026 in Review

Massachusetts Financial Services reduced its Anika Therapeutics (ANIK) stake by 3.8% in Q2 2026, selling an estimated $42.4K and leaving 71,758 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #885.

Massachusetts Financial Services first reported a position in ANIK in Q2 2013 and has held it in 14 quarters since. The position peaked at $1.21M in Q2 2024. 134 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

  • Massachusetts Financial Services held 71,758 shares of Anika Therapeutics worth $1.05M as of Q2 2026.
  • Massachusetts Financial Services sold 2,861 Anika Therapeutics shares in Q2 2026, an estimated $42.4K.
  • Anika Therapeutics made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #885 holding.
  • Massachusetts Financial Services first reported a position in Anika Therapeutics in Q2 2013 and has held it in 14 quarters since.
  • Massachusetts Financial Services's Anika Therapeutics position peaked at $1.21M in Q2 2024.
  • 134 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.